Zona Pellucida Bound Sperm vs. Embryologist Selected Sperm for Intracytoplasmic Sperm Injection

Last updated: January 19, 2026
Sponsor: IVI America
Overall Status: Completed

Phase

N/A

Condition

Infertility

Treatment

Routine Embryologist Selected Sperm

Zona Pellucida-Bound Sperm Selection for ICSI

Clinical Study ID

NCT05859152
IVIRMA-NorCal-Z01
  • Ages 18-41
  • All Genders

Study Summary

This study aims to assess the clinical significance of the intracytoplasmic sperm injection (ICSI) with zona-pellucida (ZP) bound sperm compared to ICSI with embryologist selected sperm for patients undergoing in vitro fertilization treatment of their infertility.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Undergoing their first in vitro fertilization (IVF) cycle

  • Electing single embryo transfer

  • Electing preimplantation genetic testing for aneuploidy (PGT-A) of their embryos

  • Female partners age <42 years old at start of vaginal oocyte retrieval cycle, but >18 years old.

  • Normal ovarian reserve:

  • Antimullerian hormone level (AMH) ≥ 1.2 ng/mL

  • Antral follicle count (AFC) ≥ 8

  • At least 4 mature oocytes (M2s) retrieved at the VOR procedure in order to randomize

  • At least 1 immature oocyteretrieved at the VOR procedure to perform ZP bindingco-incubation procedure

  • Intention to transfer the morphological best quality, euploid, embryo at the frozenembryo transfer procedure

Exclusion

Exclusion Criteria:

  • Contraindication to IVF

  • Clinical indication for preimplantation genetic testing (i.e., screening for singlegene disorder, chromosomal translocation, or any other disorders requiring a moredetailed embryo genetic analysis)

  • Male partner with azoospermia or oligozoospermia (<100,000 total motile spermatozoa)

  • Male partner with Y-chromosome microdeletion

  • Male partner with any Karyotype other than 46,XY

  • Male partner requiring surgically obtained sperm either via testicular or epididymalretrieval procedures

  • Uncorrected hydrosalpinges that communicate with the endometrial cavity

  • Endometrial Insufficiency, as defined by a prior cycle with maximal endometrialthickness <6mm,), or persistent endometrial fluid

  • Donor oocyte cycles

  • Gestational carriers

Study Design

Total Participants: 29
Treatment Group(s): 2
Primary Treatment: Routine Embryologist Selected Sperm
Phase:
Study Start date:
November 03, 2023
Estimated Completion Date:
September 14, 2025

Study Description

In this study, the investigators aim to determine the clinical utility of the ZP-bound sperm selection methodology for ICSI. This study will be a prospective, split cohort, randomized, control trial comparing the routine standard of sperm selection for ICSI via the embryologist versus sperm selected via ZP-binding for ICSI. Embryology, ploidy and clinical pregnancy outcomes will be assessed.

Connect with a study center

  • Reproductive Medicine Associates of Northern California

    San Francisco, California 94105
    United States

    Site Not Available

  • Reproductive Medicine Associates of Northern California

    San Francisco 5391959, California 5332921 94105
    United States

    Site Not Available

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.